Fund shareholders of Nykode Therapeutics ASA
ISIN NO0010714785 · Norway · LEI 254900UKQHWYZJD22017
- Fund shareholders
- 7
- Of which ETFs
- 4 3 other funds
- Value held
- 6M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 17,038,219 | 5.8M $ | 0.01 % | as of Mar 31, 2026 ↗ |
| THE CONTINENTAL SMALL COMPANY SERIES DFA INVESTMENT TRUST CO | 442,655 | 155K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 78,627 | 27.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional International Core Equity 2 ETF Dimensional ETF Trust | 48,071 | 16.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 46,612 | 16.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| International Vector Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 38,010 | 13.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Europe ETF SPDR INDEX SHARES FUNDS | 8,493 | 2.8K $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 0.01 % | as of Mar 31, 2026 ↗ |
| THE CONTINENTAL SMALL COMPANY SERIES DFA INVESTMENT TRUST CO | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Europe ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| International Vector Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional International Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | +5 | 17,700,687 | +3.8 % |
| 2026Q1 | 2 | 0 | 17,047,224 | +7.4 % |
| 2025Q4 | 2 | -1 | 15,871,312 | +4.3 % |
| 2025Q3 | 3 | 0 | 15,210,599 | -0.1 % |
| 2025Q2 | 3 | -4 | 15,219,347 | -1.4 % |
| 2025Q1 | 7 | -13 | 15,428,756 | -10.6 % |
| 2024Q4 | 20 | 0 | 17,265,493 | +21.1 % |
| 2024Q3 | 20 | -2 | 14,258,403 | -0.2 % |
| 2024Q2 | 22 | 0 | 14,280,873 | +2.2 % |
| 2024Q1 | 22 | -2 | 13,973,674 | +590.7 % |
| 2023Q4 | 24 | 2,023,244 |
Cite this page
Titelia. "Fund shareholders of Nykode Therapeutics ASA". https://titelia.com/en/stocks/nykode-therapeutics-asa-NO0010714785